CJC-1295 with DAC

CJC-1295 with DAC (2mg)

For laboratory research use only. Not for human consumption.

Key Benefits

The following points summarise findings from existing scientific literature. These statements are not medical claims.

• Supports research into growth hormone and IGF-1 signalling pathways
• Assists studies involving prolonged growth hormone release models
• Investigated for its role in endocrine and pituitary function research
• Demonstrates activity in metabolic and body composition study models
• Used in research exploring protein synthesis and cellular regeneration pathways
• Supports studies examining sleep-cycle and circadian rhythm regulation
• Investigated for sustained hormonal signalling due to DAC modification

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone–releasing hormone (GHRH). The addition of DAC extends the peptide’s half-life by enabling reversible binding to serum albumin, allowing for prolonged biological activity in research models.

CJC-1295 with DAC is supplied as a lyophilised (freeze-dried) powder in a sterile glass vial. Researchers can reconstitute the powder using a suitable laboratory-grade diluent for controlled experimental applications.

Product Details

Quantity: 2mg lyophilised peptide powder
Form: Sterile research-grade vial
Storage: Keep refrigerated (2–8°C). Temporary room-temperature exposure during transit is acceptable.
Reconstitution: Using sterile bacteriostatic or laboratory-grade water (per researcher protocol).

Legal & Compliance Notice

This product is supplied strictly for laboratory, scientific, and in-vitro research only.
Not for human use, medical use, diagnostic use, or veterinary use.
No health, therapeutic, or medical claims are made about this peptide.